Proluma PDLLA by Genèse Labs France Added to EG Bio’s Global Portfolio

Expanding biostimulator solutions for professional aesthetic markets

In January 2024, Proluma PDLLA, a collagen biostimulator developed by Genèse Labs France, was added to EG Bio Co., Ltd.’s global distribution portfolio as part of its ongoing portfolio expansion strategy.

Proluma PDLLA was introduced to strengthen EG Bio’s offering in the biostimulator category, supporting professional aesthetic treatments focused on long-term skin quality improvement and collagen stimulation. Through its established B2B network, EG Bio supports the structured international distribution and market development of Proluma PDLLA in alignment with regional market requirements.

The addition of Proluma PDLLA reflects close cooperation between EG Bio and Genèse Labs France, combining product expertise with global distribution capabilities. This collaboration enables clear brand positioning, reliable supply, and sustainable market entry for international partners.

With Proluma PDLLA, EG Bio continues to expand its global portfolio with category-driven products that support long-term growth and diversified opportunities for distributors worldwide.

About Genèse Labs France

Genèse Labs France is a France-based company focused on the development and management of aesthetic and dermocosmetic product portfolios for professional markets. The company works with selected manufacturing and distribution partners to support structured international expansion, emphasizing product quality, regulatory alignment, and long-term brand development.

Genèse Labs France positions its products for global markets through strategic partnerships, ensuring clear brand ownership, consistent positioning, and sustainable growth across multiple regions.